⚖

Compare Funds

See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.

MF
—ICICI Prudential India Opportunities Fund - Growth - Direct PlanDirect · Growth
₹38.02 as on 30 Oct 2026
VS
HD
HDFC MFHDFC Pharma and Healthcare Fund - Growth - Direct PlanDirect · Growth
₹21.95 as on 30 Oct 2026
▤Key Metrics Comparison
MetricMFICICI Prudential India Opportunities Fund - Growth - Direct PlanHDHDFC Pharma and Healthcare Fund - Growth - Direct Plan
Snapshot
AMC—HDFC MF
CategoryEquity - Thematic Fund - OtherEquity - Sectoral Fund - Pharma & Health Care
NAV₹38.02 (30 Oct 2026)₹21.95 (30 Oct 2026)
Rating★★★★★★★★
BenchmarkNIFTY 500 - TRIBSE Health Care - TRI
Fund ManagerSankaran NarenNikhil Mathur
Inception15 Jan 201904 Oct 2023
Returns
1Y-6.95%22.64%
3Y13.50%30.41%
5Y15.90%—
Since Inception18.69%29.15%
Risk
11.6714.07
0.810.59
0.561.59
3.4521.67
1.033.48
-10.91%-9.23%
Costs
Expense Ratio0.94%1.03%
Exit Load1% on or before 12M, Nil after 12M1% on or before 30D, Nil after 30D
Min SIP₹100₹100
Min Lumpsum₹5,000₹100
Lock-inNoneNone

Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.

◐Portfolio Overlap
ICICI Prudent…97%
HDFC MF97%
2.7%

Only 2.7% of holdings by weight are common between ICICI Prudential India Opportunities Fund - Growth - Direct Plan and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.

Common holdingICICI Prudential India Opportunities Fund - Growth - Direct PlanHDFC MF
Dr. Reddy's Laboratories Ltd.2.65%3.19%

Category context: Equity vs Equity. Open the full Screener →